Chuah S K, Sheen I S, Changchien C S, Chiu K W, Fan K D
Division of Gastroenterology, Chang Gung Memorial Hospital, Kaohsjung, Taiwan, ROC.
J Formos Med Assoc. 1996 Jun;95(6):446-51.
Amebic colitis is associated with serious complications and a high fatality rate if it progresses to its fulminant form. The purpose of this retrospective study was to determine the risk factors associated with fulminant amebic colitis. From February 1978 to February 1993, 60 adults were diagnosed with intestinal amebiasis at Chang Gung Memorial Hospital. Sixteen patients with massive bloody diarrhea, persistent systemic toxicity or signs of peritonitis were classified as having fulminant colitis, five of whom progressed to fulminant colitis after admission to the hospital. Forty-four patients with good responses to amebicides and without complications were classified as having moderate colitis. There was no amebiasis-related mortality among patients with moderate colitis. In contrast, five patients with fulminant colitis died. Early diagnosis and surgical treatment significantly decreased mortality when compared with conservative treatment. Significant factors associated with the development of fulminant intestinal amebiasis in univariate analyses were being male, age over 60 years, having an associated liver abscess, progressive abdominal pain, signs of peritonitis, leukocytosis, hyponatremia, hypokalemia and hypoalbuminemia. Only the factors of being over 60 years of age and hypokalemia were important in multivariate analyses. We conclude that early and extensive surgical treatment is mandatory for patients with typical presentations of fulminant amebic colitis on admission to the hospital, such as progression to peritonitis, persistent systemic toxemia and explosive bloody diarrhea. For other patients, especially the elderly and those with low serum potassium levels, close monitoring and observation for signs of fulminant colitis is important.
阿米巴结肠炎若发展为暴发型,则会伴有严重并发症及高死亡率。本回顾性研究的目的是确定与暴发型阿米巴结肠炎相关的危险因素。1978年2月至1993年2月,60名成年人在长庚纪念医院被诊断为肠道阿米巴病。16例出现大量血性腹泻、持续全身中毒或腹膜炎体征的患者被归类为暴发型结肠炎,其中5例在入院后发展为暴发型结肠炎。44例对杀阿米巴药反应良好且无并发症的患者被归类为中度结肠炎。中度结肠炎患者中无阿米巴病相关死亡病例。相比之下,5例暴发型结肠炎患者死亡。与保守治疗相比,早期诊断和手术治疗显著降低了死亡率。单因素分析中与暴发型肠道阿米巴病发生相关的显著因素包括男性、年龄超过60岁、伴有肝脓肿、进行性腹痛、腹膜炎体征、白细胞增多、低钠血症、低钾血症和低白蛋白血症。多因素分析中只有年龄超过60岁和低钾血症这两个因素具有重要意义。我们得出结论,对于入院时具有暴发型阿米巴结肠炎典型表现的患者,如发展为腹膜炎、持续全身毒血症和爆发性血性腹泻,早期广泛的手术治疗是必要的。对于其他患者,尤其是老年人和血清钾水平低的患者,密切监测和观察暴发型结肠炎的体征很重要。